AUG 03, 2016 12:09 PM PDT

FDA Green Lights Newest Diabetes Treatment

WRITTEN BY: Xuan Pham

Patients who suffer from diabetes type 2 may now have another option for their drug treatment. Last week, the Food and Drug Administration approved a new compound, known as Adlyxin, for the purpose of controlling blood sugar.

Adlyxin (lixisenatide) is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it works to increase the body's production of GLP-1. This protein is normally released after minutes of eating a meal and stimulates the release of insulin from the pancreas. The drug also regulates blood sugar by suppressing secretion of glucagon and slowing gastric emptying.

Currently, type 2 diabetes affects more than 29 million Americans alone. And this number is predicted to increase globally. Thus, in addition to more treatment options for diabetes, it is also crucial to reexamine the ways this disease can be prevented.
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 16, 2018
Videos
NOV 16, 2018
Greenland's Ice Hides a Massive, Ancient Impact Crater
A giant space rock once slammed into what is now Greenland. The rock is believed to be a rare iron asteroid capable of leaving such a massive dent on Earth...
NOV 18, 2018
Space & Astronomy
NOV 18, 2018
All About NASA's Plan to Drill Deeper Into Mars Than Ever Before
When NASA’s InSight lander arrives at Mars, it will land near the planet’s equator at Elysium Planitia. This location is flat, which is ideal f...
NOV 22, 2018
Videos
NOV 22, 2018
The science of gratitude
On a day like Thanksgiving, it is easy to remember all that we are thankful for. But for a while now scientists have been trying to crack the code behind t...
NOV 24, 2018
Videos
NOV 24, 2018
Gene signature predicting immune therapy
An experiment is conducted upon ECM to decide for a novel biomarker, that will help to deciding which patient can enroll fro immune therapy....
DEC 05, 2018
Cancer
DEC 05, 2018
Zika virus as a weapon against brain cancer
Glioblastoma is the most aggressive type of Brain Cancer with an average survival rate of less than two years with treatment. So what if there could be a cure for this type of cancer....
DEC 08, 2018
Cardiology
DEC 08, 2018
Adaptations Of The Heart To Chronic Exercise
We have all heard that exercise is good for us, particularly for the heart, but many don’t understand precisely how regular, long-term activity affec...
Loading Comments...